About
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, and Codimol brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
Key Metrics
as of Sep 2026Market Cap32 Cr
P/E—
Div Yield0.00 %
Book Value₹13.00
52w High₹59.80
52w Low₹29.00
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Sep 2021 | Jun 2021 | Sep 2020 | Jun 2020 | Mar 2020 | Dec 2019 | Sep 2019 | Jun 2019 | Mar 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.13 | 9.94 | 7.20 | 4.98 | 9.34 | 10.11 | 11.15 | 6.94 | 8.02 | 8.31 |
| Expenses | 9.60 | 8.31 | 7.09 | 5.38 | 9.84 | 9.65 | 9.31 | 8.05 | 7.88 | 7.64 |
| Operating Profit | 0.53 | 1.63 | 0.11 | -0.40 | -0.50 | 0.46 | 1.84 | -1.11 | 0.14 | 0.67 |
| OPM % | 5.23 | 16.40 | 1.53 | -8.03 | -5.35 | 4.55 | 16.50 | -15.99 | 1.75 | 8.06 |
| Other Income | 0.08 | 0.07 | 0.09 | 0.07 | 0.26 | 0.01 | 0.01 | 0.00 | 0.30 | 0.00 |
| Depreciation | 0.05 | 0.05 | 0.04 | 0.06 | 0.07 | 0.06 | 0.06 | 0.05 | 0.06 | 0.05 |
| Interest | 0.10 | 0.05 | 0.17 | 0.05 | 0.10 | 0.04 | 0.10 | 0.05 | 0.10 | 0.05 |
| Profit before tax | 0.46 | 1.60 | -0.01 | -0.44 | -0.41 | 0.37 | 1.69 | -1.21 | 0.28 | 0.57 |
| Tax % | 0.00 | 0.00 | 0.00 | 0.00 | 39.02 | 0.00 | 0.00 | 0.00 | -32.14 | 0.00 |
| Net Profit | 0.45 | 1.60 | -0.02 | -0.44 | -0.57 | 0.37 | 1.69 | -1.22 | 0.36 | 0.57 |
| EPS in Rs | 0.61 | 2.16 | -0.03 | -0.59 | -0.77 | 0.50 | 2.28 | -1.64 | 0.49 | 0.77 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|
| Sales | 25.18 | 37.54 | 31.03 |
| Expenses | 27.95 | 36.86 | 30.54 |
| Operating Profit | -2.77 | 0.68 | 0.49 |
| OPM % | -11.00 | 1.81 | 1.58 |
| Other Income | 0.80 | 0.29 | 0.32 |
| Interest | 0.39 | 0.29 | 0.25 |
| Depreciation | 0.18 | 0.24 | 0.21 |
| Profit before tax | -2.54 | 0.44 | 0.35 |
| Tax % | -0.39 | 36.36 | -25.71 |
| Net Profit | -2.52 | 0.28 | 0.43 |
| EPS in Rs | -3.40 | 0.38 | 0.58 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Sep 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|
| Equity Capital | 7.42 | 7.42 | 7.42 |
| Reserves | 2.19 | 3.69 | 3.41 |
| Borrowings | 4.11 | 2.38 | 0.65 |
| Other Liabilities | 11.23 | 8.85 | 7.86 |
| Total Liabilities | 24.95 | 22.34 | 19.34 |
| Fixed Assets | 3.53 | 2.30 | 2.06 |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 0.28 | 0.27 | 0.29 |
| Other Assets | 21.14 | 19.77 | 16.99 |
| Total Assets | 24.95 | 22.34 | 19.34 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2020 | Mar 2019 |
|---|---|---|
| Debtor Days | 68.16 | 53.29 |
| Inventory Days | 90.00 | 119.66 |
| Days Payable | 83.71 | 88.95 |
| Cash Conversion Cycle | 74.46 | 83.99 |
| Working Capital Days | 25.18 | 27.88 |
| ROCE % | 5.85 | — |
Corporate Actions
No corporate actions recorded.